A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine
Molecular Pharmacology · 2026-10 · 108 (10) · 100155
DOI: 10.1016/j.molpha.2026.100155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2026-10. Verfasst von Joelle Reich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, Piscataway, New Jers…. Hauptthemen laut MEDLINE: Carvedilol, Potassium Channels, Tandem Pore Domain, Fluphenazine, Potassium Channel Blockers. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, Piscataway, New Jersey; Department of Pharmacology, Robert Wood Johnson Medical School, Ru…
- Department of Anesthesiology, Weill Cornell Medical College, New York, New York.
- Clarendon Laboratory, Department of Physics, University of Oxford, Oxford, United Kingdom; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Reich, J., Riegelhaupt, P. M., Tucker, S. J., & McClenaghan, C. (2026). A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine. Molecular Pharmacology, 108(10), 100155. https://doi.org/10.1016/j.molpha.2026.100155
Vancouver
Reich J, Riegelhaupt PM, Tucker SJ, McClenaghan C. A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine. Molecular Pharmacology. 2026;108(10):100155. doi:10.1016/j.molpha.2026.100155
BibTeX
@article{Reich2026,
author = {Reich, Joelle and Riegelhaupt, Paul M and Tucker, Stephen J and McClenaghan, Conor},
title = {A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine},
journal = {Molecular Pharmacology},
year = {2026},
volume = {108},
number = {10},
pages = {100155},
doi = {10.1016/j.molpha.2026.100155}
}
EUVIMED